AOBI Projected Dividend Yield

American Oriental Bioengineering Inc ( OTCBB : AOBI )

American Oriental Bioengineering is a pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. Co.'s manufacturing business consists of three main product categories, including prescription pharmaceutical products, over-the-counter pharmaceutical products and nutraceutical products. Co. sells its products primarily to hospitals, clinics, pharmacies and retail outlets in all provinces, including rural areas and cities in China. Co.'s primary products include Shuanghuanglian Lyophilized Injection Powder and Cease Enuresis Soft Gel. As of Dec 31 2012, Co. marketed 109 pharmaceutical products primarily in China.

20 YEAR PERFORMANCE RESULTS